Delivery Order SPE2DB20D1100-SPE2DB25FD9D1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20K to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count) under a firm fixed-price contract structure. The award, issued on May 3, 2025, with an ultimate completion date of May 5, 2025, represents a competitive, non-set-aside procurement fulfilled by AmerisourceBergen's Corporate Office facility located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,798.06 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units). This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $4,684.32 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Adderall 20 mg tablets (100 count). This firm fixed-price contract, with an ultimate completion date of August 13, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is not set-aside and was competitively awarded, with performance of work to occur at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Adderall 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $2,824.08, with an ultimate completion date of August 21, 2025. The contract was competitively awarded with no set-aside designation and is to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,740.47 for Adderall 20 mg tablets (100 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $4,431.07 and a firm fixed price structure. The contract is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Adderall 20 mg tablets (100-count). This competitive award, with a ceiling value of $4,056.85 and a firm fixed price structure, is scheduled for ultimate completion by July 28, 2025. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall 15 mg tablets (100-count units) with a ceiling value of $2,083.55. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9D1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,899.03 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement running through December 2026 that serves as the primary vehicle for global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains an extensive portfolio of federal medical supply contracts with the DLA and other government healthcare agencies, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting demonstrates capability across a broad spectrum of pharmaceutical products ranging from specialty medications and vaccines to generic drugs and medical devices. This specific delivery order for a controlled substance supports the ongoing pharmaceutical supply chain requirements of military and veteran healthcare systems under the DLA Troop Support Medical program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/7/25 |